Ting Zhu
Zhuhai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Exploring the medicinal value of Boletus from the dual perspectives of modern pharmacology and traditional Chinese medicine theory.
Journal: Frontiers in pharmacology
Published: January 20, 2026
Microbial metabolites contribute to the pathogenesis of metabolic dysfunction-associated fatty liver disease in high-fat diet-fed mice.
Journal: Microbial pathogenesis
Published: September 15, 2025
High-fat diet promotes kidney lipid droplet deposition contributing to the pathogenesis of obesity-related glomerulopathy in mice through gut microbial metabolism.
Journal: Genomics
Published: August 28, 2025
C3G improves lipid droplet accumulation in the proximal tubules of high-fat diet-induced ORG mice.
Journal: Pharmacological research
Published: September 15, 2024
Renoprotective effects of empagliflozin in high-fat diet-induced obesity-related glomerulopathy by regulation of gut-kidney axis.
Journal: American journal of physiology. Cell physiology
Published: August 26, 2024
Intercellular Communication Network of CellChat Uncovers Mechanisms of Kidney Fibrosis Based on Single-Cell RNA Sequencing.
Journal: Kidney & blood pressure research
Published: May 28, 2024
Adherence to a Mediterranean diet is associated with a lower risk of diabetic kidney disease among individuals with hyperglycemia: a prospective cohort study.
Journal: BMC medicine
Published: November 21, 2023
The role of microbial metabolites in diabetic kidney disease.
Journal: Heliyon
Published: November 14, 2022
Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5/6-nephrectomy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 17, 2022
Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism.
Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism.
Journal: Journal of translational medicine
Published: June 10, 2022
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease.
Journal: Journal of translational medicine
Published: April 09, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026